| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 1800 | 2022 |
| Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles F Vega, CC Chang, LJ Medeiros, MM Udden, JH Cho-Vega, CC Lau, ... Modern Pathology 18 (6), 806-815, 2005 | 410 | 2005 |
| Leukemia cutis JH Cho-Vega, LJ Medeiros, VG Prieto, F Vega American journal of clinical pathology 129 (1), 130-142, 2008 | 352 | 2008 |
| Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center S Li, X Feng, T Li, S Zhang, Z Zuo, P Lin, S Konoplev, CE Bueso-Ramos, ... The American journal of surgical pathology 37 (1), 14-23, 2013 | 241 | 2013 |
| Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase–positive anaplastic large cell lymphoma F Vega, LJ Medeiros, V Leventaki, C Atwell, JH Cho-Vega, L Tian, ... Cancer research 66 (13), 6589-6597, 2006 | 235 | 2006 |
| Extranodal lymphomas of the head and neck F Vega, P Lin, LJ Medeiros Annals of diagnostic pathology 9 (6), 340-350, 2005 | 234 | 2005 |
| Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats J Díez, A Panizo, M Hernández, F Vega, I Sola, MA Fortuño, J Pardo Hypertension 30 (5), 1029-1034, 1997 | 210 | 1997 |
| Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment GS Falchook, F Vega, NH Dang, F Samaniego, MA Rodriguez, ... Annals of oncology 20 (6), 1080-1085, 2009 | 189 | 2009 |
| PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma SA Meadows, F Vega, A Kashishian, D Johnson, V Diehl, LL Miller, ... Blood, The Journal of the American Society of Hematology 119 (8), 1897-1900, 2012 | 185 | 2012 |
| ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma RR Singh, K Kunkalla, C Qu, E Schlette, SS Neelapu, F Samaniego, ... Oncogene 30 (49), 4874-4886, 2011 | 182 | 2011 |
| Clonal heterogeneity in mycosis fungoides and its relationship to clinical course F Vega, R Luthra, LJ Medeiros, V Dunmire, SJ Lee, M Duvic, D Jones Blood, The Journal of the American Society of Hematology 100 (9), 3369-3373, 2002 | 159 | 2002 |
| Hepatosplenic and other γδ T-cell lymphomas F Vega, LJ Medeiros, P Gaulard American journal of clinical pathology 127 (6), 869-880, 2007 | 148 | 2007 |
| Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma RR Singh, JH Cho-Vega, Y Davuluri, S Ma, F Kasbidi, C Milito, ... Cancer research 69 (6), 2550-2558, 2009 | 118 | 2009 |
| Hepatosplenic gamma/delta T-cell lymphoma in bone marrow: a sinusoidal neoplasm with blastic cytologic features F Vega, LJ Medeiros, C Bueso-Ramos, D Jones, R Lai, R Luthra, ... American journal of clinical pathology 116 (3), 410-419, 2001 | 114 | 2001 |
| Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment S Rawal, F Chu, M Zhang, HJ Park, D Nattamai, S Kannan, R Sharma, ... The Journal of Immunology 190 (12), 6681-6693, 2013 | 113 | 2013 |
| Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma JE Kim, RR Singh, JH Cho-Vega, E Drakos, Y Davuluri, FA Khokhar, ... Modern Pathology 22 (10), 1312-1320, 2009 | 112 | 2009 |
| CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ... Blood, The Journal of the American Society of Hematology 138 (12), 1081-1085, 2021 | 109 | 2021 |
| Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation RR Singh, JE Kim, Y Davuluri, E Drakos, JH Cho-Vega, HM Amin, F Vega Leukemia 24 (5), 1025-1036, 2010 | 106 | 2010 |
| Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies A Quintas-Cardama, W Tong, T Manshouri, F Vega, PA Lennon, J Cools, ... Leukemia 22 (6), 1117-1124, 2008 | 105 | 2008 |
| Epstein–Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms LV Abruzzo, CM Rosales, LJ Medeiros, F Vega, R Luthra, JT Manning, ... The American journal of surgical pathology 26 (5), 630-636, 2002 | 104 | 2002 |
